首页> 外文期刊>Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis >Candidate reference measurement procedure for determination of urea in serum by liquid chromatography-tandem mass spectrometry
【24h】

Candidate reference measurement procedure for determination of urea in serum by liquid chromatography-tandem mass spectrometry

机译:液相色谱 - 串联质谱法测定血清中尿素的候选参考测量程序

获取原文
获取原文并翻译 | 示例
           

摘要

Urea is an important indicator of liver and kidney disease, and very frequently determined in clinical chemistry. The reference measurement procedures (RMPs) for serum urea recognized by the Joint Committee for Traceability in Laboratory Medicine are spectrophotometry, and isotope dilution (ID)-mass spectrometry (MS) coupled with gas chromatography. This study investigated a candidate RMP (cRMP) for detecting serum urea directly via ID-liquid chromatography (LC)-MS/MS, without derivatization, which simplifies pre-processing samples. The cRMP was developed and evaluated relative to the recognized RMP, inter- and intra-laboratories. The intra-precisions were 1.35%, 1.98% and 1.47% at 4.95, 24.74 and 31.36 mmol/L, respectively; inter-precision was 2.10%, 2.60% and 2.10%. The relative bias for the measurement of standard human serum (SRM 909c) was -0.49%. The relative biases were 0.41% and 0.02% for IFCC-RELA (International Federation of Clinical Chemistry and Laboratory Medicine-External Quality Assessment Scheme [EQAS] for reference laboratories) 2015A and 2015B. The linearity response between 2.4 mmol/L and 53.7 mmol/L was R-2= 0.9989. No carryover, ion suppression, or interference was detected. Correlation was acceptable with the reference spectrophotometry (R-2 = 0.9985, P 0.0001). Between our laboratory and other reference laboratories, the absolute deviation range for IFCC-RELA 2016A and 2016B was from -0.63 to 1.52 mmol/L. This well-characterized cRMP for urea can provide a base of accuracy for the traceability of clinical systems. (C) 2018 Elsevier B.V. All rights reserved.
机译:尿素是肝肾疾病的重要指标,并且在临床化学中经常确定。在实验室药物中可追溯性识别的血清尿素的参考测量程序(RMP)是分光光度法,同位素稀释(ID) - 与气相色谱相连的同位素稀释度(ID)光谱法(MS)。本研究研究了通过ID-液相色谱(LC)-MS / MS直接检测血清尿素的候选RMP(CRMP),而不会衍生化,这简化了预处理样品。 CRMP是相对于公认的RMP,和实验室内的公认和实验室的评估。在4.95,20.74和31.36mmol / L的内部诊断分别为1.35%,1.98%和1.47%;精度相互精确为2.10%,2.60%和2.10%。用于测量标准人血清(SRM 909C)的相对偏压为-0.49%。 IFCC-RELA的相对偏见为0.41%和0.02%(国际临床化学和实验室医学 - 外部质量评估计划[EQAS]参考实验室)2015A和2015B。 2.4mmol / L和53.7 mmol / L之间的线性响应是R-2 = 0.9989。没有检测到携带,离子抑制或干扰。参考分光光度法(R-2 = 0.9985,P <0.0001)可以接受相关性。在我们的实验室和其他参考实验室之间,IFCC-Rela 2016a和2016b的绝对偏差范围为-0.63至1.52 mmol / l。这种特征在于尿素的CRMP可以为临床系统的可追溯性提供精度的准确性。 (c)2018年elestvier b.v.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号